The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US.
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
A recent study reveals many websites selling compounded versions of weight-loss drugs do not inform users of risks, often ...
KRLD Radio Dallas on MSN2h
Nicotine pouches get FDA approval, with some calling them Gen Z's favorite weight loss hackLittle pouches of nicotine sold by the brand ZYN were given the green light for marketing this week through the U.S. Food and ...
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
By Bhanvi Satija and Christy Santhosh (Reuters) -Websites selling compounded versions of popular weight-loss drugs from Novo ...
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
The Centers for Medicare & Medicaid Services just announced 15 new drugs it wants to lower the cost for including popular, ...
A new analysis finds nearly half of the compounded GLP-1 websites didn’t include information on adverse effects, warnings, ...
Ozempic, an anti-diabetes medication, has gained popularity for its off-label use in weight loss among celebrities, despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback